Clinical trial
A Phase I Study of Nivolumab and Intratumoral BO 112 for Resectable Soft Tissue Sarcoma
NCT04420975 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of Nivolumab and Intratumoral BO 112 for Resectable Soft Tissue Sarcoma
- Lead sponsor
- Jonsson Comprehensive Cancer Center
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- October 14, 2020
- Completion date
- January 31, 2028
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
leiomyosarcoma, malignant peripheral nerve sheath tumor, myxofibrosarcoma, pleomorphic rhabdomyosarcoma, resectable dedifferentiated liposarcoma, resectable soft tissue sarcoma, resectable undifferentiated pleomorphic sarcoma, soft tissue fibrosarcoma, spindle cell sarcoma, stage i retroperitoneal sarcoma ajcc (american joint committee on cancer) v8, stage i soft tissue sarcoma of the trunk and extremities ajcc v8, stage ia retroperitoneal sarcoma ajcc v8, stage ia soft tissue sarcoma of the trunk and extremities ajcc v8, stage ib retroperitoneal sarcoma ajcc v8, stage ib soft tissue sarcoma of the trunk and extremities ajcc v8, stage ii retroperitoneal sarcoma ajcc v8, stage ii soft tissue sarcoma of the trunk and extremities ajcc v8, stage iii retroperitoneal sarcoma ajcc v8, stage iii soft tissue sarcoma of the trunk and extremities ajcc v8, stage iiia retroperitoneal sarcoma ajcc v8, stage iiia soft tissue sarcoma of the trunk and extremities ajcc v8, stage iiib retroperitoneal sarcoma ajcc v8, stage iiib soft tissue sarcoma of the trunk and extremities ajcc v8, storiform-pleomorphic malignant fibrous histiocytoma, synovial sarcoma, undifferentiated high grade pleomorphic sarcoma of bone, undifferentiated pleomorphic sarcoma, undifferentiated pleomorphic sarcoma with osteoclast-like giant cells, undifferentiated pleomorphic sarcoma, inflammatory variant, undifferentiated spindle cell sarcoma